Placenta, Fetal Liver, Sectional Ductus Venosus Volumes Examined by Three-dimensional Ultrasound in the Second Trimester

Sanliurfa Mehmet Akif Inan Education and Research Hospital

Status: Completed

Conditions: PLACENTA VOLUME; Gestational Diabetes; 3D SONOGRAPHY; DUCTUS VENOSUS VOLUME; FETAL LİVER VOLUME

Treatments: Other: 3D sonography

Study type: Interventional

Funder types: Other

Identifiers

NCT06178250

2011-KAEK-25 2021/10-09

Details and patient eligibility

About

Investigators measured the placenta, fetal liver and ductus venosus volumes of pregnant women with GDM diagnosis and normal glycemic indices in the second trimester.Investigators aimed to correlate measurements with maternal/fetal outcomes and evaluate their success in predicting poor obstetric outcomes

Full description

GDM screening may not always be possible with OGTT performed in limited weeks of gestation. In addition, mid-trimester ultrasound scanning is done in all pregnancies. Therefore, measurement of placental volume and fetal liver volume may be an alternative method for the diagnosis of GDM. In order to predict GDM in the second trimester, the use of 3D sonography and VOCAL (Virtual Organ Computer Aided Analysis) technology in high-risk pregnant women and their cost-effectiveness rates should be investigated further. Multicenter randomized controlled studies with more patients are needed to be able to say more clearly.

Enrollment: 139 patients

Sex: Female

Ages: 18 to 45 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• singleton pregnancy
• diagnosed with GDM

Exclusion criteria

• multiple pregnancy
• congenital anomalies
• gestational hypertansion
• preeclampsia

Trial design

Primary purpose: Other

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

139 participants in 1 patient group

placenta, fetal liver, sectional ductus venosus volumes between 24-29 weeks pregnant women

Other group

Description:

The placenta, fetal liver and ductus venosus volumes of 46 patients diagnosed with GDM and 93 patients without a GDM diagnosis between 24-29 weeks were evaluated with 3D ultrasound.

Treatment:

Other: 3D sonography